Jesper Høiland retires as chief commercial officer of Ascendis Pharma

Former executive vice president of Novo Nordisk, US, Jesper Høiland has decided to step down from his role as global chief commercial officer at Ascendis Pharma.

Jesper Høiland, outgoing global chief commercial officer of Ascendis Pharma | Photo: Radius Health / PR

Danish biotech firm Ascendis Pharma, which is publicly listed in the US, has announced that Jesper Høiland, a former long-standing executive at Novo Nordisk in the US, is retiring from his role as global chief commercial officer, the firm reports on Monday.

According to the statement, Høiland intends to return from the US to Denmark with his family. A similar reason was given back in 2020, when Høiland left US-based Radius Health, where he had served as chief executive.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs